Phibro Animal Health | PAHC - Devedores Comerciais





Devedores Comerciais Alterar Data
Align Technology USD 1.15B 23.28M 2026-06
ANI Pharmaceuticals USD 274.47M 19.04M 2026-06
Aurora Cannabis CAD 44.58M 3.68M 2026-03
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Canopy Growth CAD 36.29M 104.13M 2026-03
Corcept Therapeutics USD 76.92M 37.85M 2026-06
Eli Lilly USD 23.48B 2.3B 2026-06
Henry Schein USD 1.76B 44M 2026-06
Idexx Laboratories USD 627.08M 70.13M 2026-06
Knight Therapeutics CAD 183M 7.46M 2025-12
Merck USD 12.21B 435M 2026-03
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Pacira USD 132.42M 6.78M 2026-06
Phibro Animal Health USD 215.87M 2.02M 2025-12
Prestige Brands USD 187.36M 4.56M 2026-06
Supernus Pharmaceuticals USD 211.66M 29.47M 2026-06
Zoetis USD 1.57B 65M 2026-06